RECURRENT STROKE IN THE WARFARIN VERSUS ASPIRIN IN REDUCED EJECTION FRACTION (WARCEF) TRIAL

BACKGROUND AND PURPOSE: WARCEF randomized 2305 patients in sinus rhythm with ejection fraction (EF) ≤35% to warfarin (INR 2.0–3.5) or aspirin 325 mg. Warfarin reduced the incident ischemic stroke (IIS) hazard rate by 48% over aspirin in a secondary analysis. The IIS rate in heart failure (HF) is too...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cerebrovasc Dis
Main Authors: Pullicino, Patrick M., Qian, Min, Sacco, Ralph L., Freudenberger, Ron, Graham, Susan, Teerlink, John R., Mann, Douglas, Di Tullio, Marco R., Ponikowski, Piotr, Lok, Dirk J., Anker, Stefan D., Lip, Gregory Y.H., Estol, Conrado J., Levin, Bruce, Mohr, J.P., Thompson, John L. P., Homma, Shunichi
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4245504/
https://ncbi.nlm.nih.gov/pubmed/25300706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365502
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker